Advertisement

Annals of Hematology

, Volume 98, Issue 8, pp 2009–2011 | Cite as

Eltrombopag combined with cyclosporine may have an effect on very severe aplastic anemia

  • Hai Cheng
  • Xue Wang
  • Dian Zhou
  • Jiang Cao
  • Andre Larochelle
  • Kai-lin XuEmail author
Letter to the Editor
  • 248 Downloads

Notes

Acknowledgements

Thanks to A. Larochelle for reading and editing this manuscript.

Authorship contributions

H. Cheng, D. Zhou, and X. Wang collected the data and wrote the manuscripts and contributed equally. All authors approved the final manuscript.

Funding information

This work is supported by Young Medical Talents of Jiangsu Province (QNRC2016793).

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

References

  1. 1.
    Olnes MJ, Scheinberg P, Calvo KR, Desmond R, Tang Y, Dumitriu B, Parikh AR, Soto S, Biancotto A, Feng X, Lozier J, Wu CO, Young NS, Dunbar CE (2012) Eltrombopag and improved hematopoiesis in refractory aplastic anemia. N Engl J Med 367:11–19CrossRefGoogle Scholar
  2. 2.
    Desmond R, Townsley DM, Dumitriu B, Olnes MJ, Scheinberg P, Bevans M, Parikh AR, Broder K, Calvo KR, Wu CO, Young NS, Dunbar CE (2014) Eltrombopag restores trilineage hematopoiesis in refractory severe aplastic anemia that can be sustained on discontinuation of drug. Blood 123:1818–1825CrossRefGoogle Scholar
  3. 3.
    Townsley DM, Scheinberg P, Winkler T, Desmond R, Dumitriu B, Rios O, Weinstein B, Valdez J, Lotter J, Feng X, Desierto M, Leuva H, Bevans M, Wu C, Larochelle A, Calvo KR, Dunbar CE, Young NS (2017) Eltrombopag added to standard immunosuppression for aplastic anemia. N Engl J Med 376:1540–1550CrossRefGoogle Scholar
  4. 4.
    Rodgers GM, Gilreath JA (2018) Eltrombopag as initial monotherapy for severe aplastic anemia. Ann Hematol 97:1517–1518CrossRefGoogle Scholar
  5. 5.
    Wu B, Cai J, Yingshi L, Ruihong D (2018) Eltrombopag combined with G-CSF and cyclosporine could effect for severe acquired aplastic anemia. Blood 132:5110CrossRefGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Department of HematologyThe Affiliated Hospital of Xuzhou Medical UniversityXuzhouChina
  2. 2.National Heart, Lung and Blood InstituteNational Institutes of HealthBethesdaUSA
  3. 3.Blood Diseases InstituteXuzhou Medical UniversityXuzhouChina
  4. 4.Key Laboratory of Bone Marrow Stem CellXuzhouChina

Personalised recommendations